This course has expired. View available courses.
Endocrinologie
Diabète de type 2 : de nouvelles lignes directrices qui vont bien au-delà de l’abaissement du taux d’HbA1c – Le conseil canadien de l’éducation continue en pharmacie (CCECP)
La maladie cardiovasculaire est la principale cause de morbidité et de mortalité chez les personnes atteintes d’un diabète de type 2. Les données probantes provenant de récents essais sur l’innocuité cardiovasculaire chez les patients atteints d’un diabète de type 2 modifient la pratique clinique et pharmaceutique de manières qui vont au-delà de l’abaissement du taux d’HbA1c. Le présent programme appuiera les pharmaciens dans la compréhension de la façon dont les approches pharmaceutiques pour ces patients ont changé lors de la mise à jour des lignes directrices de Diabète Canada en avril 2018, et de l’évolution du rôle des pharmaciens dans la protection vasculaire et rénale.
DURATION
1.5 hrs
PROFESSION
# OF CREDITS
1.5
ACCREDITATION
CCCEP
EXPIRY DATE
2019-10-09
La maladie cardiovasculaire est la principale cause de morbidité et de mortalité chez les personnes atteintes d’un diabète de type 2. Les données probantes provenant de récents essais sur l’innocuité cardiovasculaire chez les patients atteints d’un diabète de type 2 modifient la pratique clinique et pharmaceutique de manières qui vont au-delà de l’abaissement du taux d’HbA1c. Le présent programme appuiera les pharmaciens dans la compréhension de la façon dont les approches pharmaceutiques pour ces patients ont changé lors de la mise à jour des lignes directrices de Diabète Canada en avril 2018, et de l’évolution du rôle des pharmaciens dans la protection vasculaire et rénale.
Faculty
Sean Wharton, M.D., Pharm. D., FRCPC
Jessie Haggai, B. Sc. (Pharm.), EAD
Rob Roscoe, B. Sc. (Pharm.), ACPR, EAD, formateur agréé en utilisation des pompes à insuline, EAD
Learning objectives
After completion of the program, the participant will be able to:
- Describe how cardiovascular outcomes trials have informed changes to the Diabetes Canada treatment algorithm for type 2 diabetes mellitus (T2DM).
- Analyze the benefits and risks of antihyperglycemic treatments that have demonstrated cardiovascular benefit in second-line treatment of T2DM.
- Counsel patients with T2DM to support vascular protection in the pharmacy.
Accreditation
#
of credits: 1.5
Duration: 1.5 hrs
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
